Evidence map›Paper›PMID 34164706›Full record

ReviewVirchows Archiv : an international journal of pathology2022

Sentinel lymph node assessment in breast cancer-an update on current recommendations.

Gábor Cserni, Aoife Maguire, Simonetta Bianchi, Ales Ryska, Anikó Kovács

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Virchows Archiv : an international journal of pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Validation of prognostic and predictive value of total tumoral load after primary systemic therapy in breast cancer using OSNA assay.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Observational
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 5 countries.

Gábor CserniDepartment of Pathology, Bács-Kiskun County Teaching Hospital, Kecskemét, Hungary. cserni@freemail.hu.ORCID http://orcid.org/0000-0003-1344-7744
Aoife MaguireDepartment of Histopathology, Breast Check, Irish National Breast Screening Programme & St. Vincent's University Hospital, Dublin, Ireland.ORCID http://orcid.org/0000-0002-9120-6383
Simonetta BianchiDepartment of Health Sciences, Division of Pathological Anatomy, University of Florence, Florence, Italy.ORCID http://orcid.org/0000-0002-2605-4758
Ales RyskaThe Fingerland Department of Pathology, Charles University Medical Faculty Hospital, Hradec Kralove, Czech Republic.ORCID http://orcid.org/0000-0002-3051-2280
Anikó KovácsDepartment of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.ORCID http://orcid.org/0000-0001-7711-4418
Charles University · CZSahlgrenska University Hospital · SESt. Vincent's University Hospital · IEUniversity of Florence · ITUniversity of Szeged · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sentinel lymph node biopsy (SLNB) has become the preferred method of surgical pathological nodal staging of early breast cancer by the end of the nineties. As the most likely sites of metastasis, the SLNs allow a more precise staging, and indeed gross sectioning, step sectioning, immunohistochemistry, and molecular staging methods have been used to disclose metastatic involvement of these lymph nodes. This review summarizes the backgrounds of SLNB, trends in related surgery and pathology. It also gives an insight into European National recommendations related to SLN and divergent daily practices in European pathology departments, on the basis of replies to questionnaires from 84 pathologists from 38 European countries. The questionnaires revealed the post-neoadjuvant setting as an area where a significant minority of pathologists report less confidence in classifying residual nodal involvement into TNM categories. The review also summarizes the neoadjuvant therapy-related aspects of SLNB.

Indexed as

Breast NeoplasmsSentinel Lymph NodeAxillaFemaleHumansLymphatic MetastasisLymph Node ExcisionLymph NodesNeoadjuvant TherapyNeoplasm StagingSentinel Lymph Node BiopsyBreast cancerLymph nodesNeoadjuvant treatmentQuestionnaireSentinel lymph nodes

Identifiers

PMID34164706
OpenAlexW3173222191

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.